Faron Announces Release of Research Confirming Bexmarilimab Efficacy and Safety in MATINS Trial

FINLAND - Faron Pharmaceuticals Oy , a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the release of further insights from its Phase... | April 25, 2023

Related Keywords

Finland ,Maija Hollmen ,Jennifer Smith Parker ,Faron Pharmaceuticals Oy ,First North ,Chief Scientific Officer ,Common Lymphatic Endothelial ,Vascular Endothelial Receptor ,News Publishing ,Faron Pharmaceuticals Oy Stock Exchange ,News ,Information ,Press Release ,Aaron ,Pharmaceuticals ,Y ,Iopharmaceutical ,Company ,Ocused ,N ,Tackling ,Cancers ,Cia ,Novel ,Oday ,Nnounces ,The ,Release ,F ,Urther ,Insights ,Rom ,Ts Farn Fi4000153309 ,